अध्ययन का उद्देश्य: To evaluate the maximum tolerated dose (MTD) of choline salicylate (CS) that can be combined with selinexor twice weekly in patients with relapsed/refractory diffuse large B cell lymphoma (DLBCL) or mantle cell lymphoma (MCL). (Primary)
प्रमुख अन्वेषक: Jonas Paludo, M.D., Mayo Clinic in Rochester, Minnesota, United States
संपर्क जानकारी: Clinical Trials Referral Office Phone: +1-855-776-0015 Email: mayocliniccancerstudies@mayo.edu
अनुरोधित रोगी सहभागिता: 18 Years and older
ClinicalTrials.gov पहचानकर्ता: एनसीटी04640779